TAK875 structure, CAS 1000413-72-8

TAK875

CAS Number1000413-72-8

SynonymsFasiglifam; TAK 875; TAK-875; Fasiglifam (INN); tak875

Molecular FormulaC29H32O7S

Molecular Weight524.625

Purity

Density1.3±0.1 g/cm3

Boiling Point739.1±60.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1170179 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1000413-72-8 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1000413-72-8
Catalog No.2A-1170179
Chinese NameTAK875-消旋体
SynonymsFasiglifam; TAK 875; TAK-875; Fasiglifam (INN); tak875
Molecular FormulaC29H32O7S
Molecular Weight524.625
Density1.3±0.1 g/cm3
Boiling Point739.1±60.0 °C at 760 mmHg
Storage Condition2-8℃
ApplicationFasiglifam (TAK-875) is a potent, orally available, selective GPR40 agonist with an EC50 of 72 nM.
PubChem ID50088191
SMILESCc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OCC3CC(=O)O)c1
InChIInChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
InChI KeyBZCALJIHZVNMGJ-HSZRJFAPSA-N
Transport InfoProduct name: (3S)-6-[[2',6'-dimethyl-4'-[3-(methanesulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid
Related Products in Specialty Chemicals
VU 0357121433967-28-32A-1170174
Pilaralisib934526-89-32A-1170175
PD 173074219580-11-72A-1170176
Vicriviroc Malate541503-81-52A-1170177
GSK28382321443461-21-92A-1170178
Tarafenacin385367-47-52A-1170180
sp-4201221411-72-82A-1170181
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide587841-73-42A-1170182
PD 169316152121-53-42A-1170185
BIX 021881094614-84-22A-1170186
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA